Surgery and radiotherapy in the treatment of cutaneous melanoma
about
Systemic treatments for metastatic cutaneous melanomaElectrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumorsSurgery of primary melanomas.Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases.20 years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose mattersElectrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma.Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases.Enhancement of electroporation facilitated immunogene therapy via T-reg depletion.Limb salvage surgery following resection of a melanoma: Foot and ankle reconstruction using cutaneous flaps.Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden.Design, synthesis, and biological evaluation of N-acetyl-S-(p-chlorophenylcarbamoyl)cysteine and its analogs as a novel class of anticancer agents.A new understanding in the epidemiology of melanomaMelanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032.Controversies in the diagnosis and treatment of early cutaneous melanoma.Racial differences in survival after surgical treatment for melanomaThe Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options.The evaluation of immunotherapy and chemotherapy treatment on melanoma: a network meta-analysisThe cost of unresectable stage III or stage IV melanoma in ItalyCalcaneal melanoma; our rare case and review of the literature.TORC1 suppression predicts responsiveness to RAF and MEK inhibition in BRAF-mutant melanoma.Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?Melanoma: diagnosis, staging, and treatment. Consensus group recommendations.Chirurgische Behandlung von Melanomen in der Schwangerschaft: eine praktische Anleitung.Surgical treatment of melanoma in pregnancy: a practical guideline.Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia.Transcriptional repression of IFNβ1 by ATF2 confers melanoma resistance to therapy.Efficacy of different sequences of radio- and chemotherapy in experimental models of human melanoma.Adjuvant high-dose interferon-{alpha} for resected melanoma in a patient with HIV infection.Nanobiotechnological Nanocapsules Containing Polyhemoglobin-Tyrosinase: Effects on Murine B16F10 Melanoma Cell Proliferation and AttachmentAnti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial.Transplantable Melanomas in Hamsters and Gerbils as Models for Human Melanoma. Sensitization in Melanoma Radiotherapy-From Animal Models to Clinical Trials.
P2860
Q24194804-43C507BB-D558-45EB-B4ED-BC3AF1432E4EQ26822537-03ABC226-E5D6-4791-8252-72A9E9092466Q30356095-382124BF-26E0-4442-8FC5-643CB0A254DBQ33955599-19D577AF-9A9B-486B-802B-3E92C9BA8B62Q34006197-D987A29F-42D2-4175-8B5A-52C289FA0F93Q34020065-B5F7C12B-B36D-40DC-A021-6B3829B703BDQ34022431-373497AA-636D-448A-BA7B-6AD98205A1C0Q34072036-F30B71A7-E807-4E5E-9A15-28D4A88C7CD2Q34293328-BBCDF9E3-8AA6-4595-8E24-E28BC7B4F21AQ34372934-B7878B0B-4919-4304-81FC-D2EE9433F72CQ34520444-E790BE9F-D752-4F8F-A231-02FA9D8934E9Q34625205-1D939AB3-2BE9-4C8E-9FCA-39852B45CC6FQ34634256-B25EC9C5-8205-4B7A-A05A-CBF7A6DDBA02Q35349822-48B4BBED-97CA-4181-8BC2-FA0FDB519B35Q35600763-C62AC661-50E8-4484-8FC4-07C1436188E2Q36102807-45F0048F-2C20-474A-80CC-73CD08758149Q36192538-63F0D5FE-95EC-4AC5-A60D-7C4E9D639EA4Q36523720-A4255A10-CC1C-486B-B821-685639EF92E6Q36946322-83168C61-2B50-4001-88F7-443AF13208CEQ37401151-61EFF721-CE98-48F5-B8C5-A18A1BC34C2EQ37513298-C03EC120-E174-4EE5-9183-5A678219E6A6Q38242004-6DE1F449-3562-4A00-BE56-D9A6C37CC575Q38848123-DF90A24C-3CE6-43D4-AC48-CBBF6D70791CQ38848127-6833CF55-A186-4003-ACAE-F902C05B5FC6Q38872439-05C3E3B9-CB15-472D-AEDB-3E1FB35AFB93Q38904811-7786DF05-F325-48DE-B503-B5F077AFA99AQ39018908-4F82F61E-6716-4159-9750-7BBF240FD870Q39508180-A7436386-0684-4AEC-8AC1-4D51AEAFABEFQ41667860-6A54EDC1-8757-4994-A351-EB4AB72FD22FQ52597538-B35ED0DA-B06C-46F4-8DA7-59232F8272C3Q52929781-ADAB084D-3B64-4CD2-B7DA-81118176F666
P2860
Surgery and radiotherapy in the treatment of cutaneous melanoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Surgery and radiotherapy in the treatment of cutaneous melanoma
@en
Surgery and radiotherapy in the treatment of cutaneous melanoma.
@nl
type
label
Surgery and radiotherapy in the treatment of cutaneous melanoma
@en
Surgery and radiotherapy in the treatment of cutaneous melanoma.
@nl
prefLabel
Surgery and radiotherapy in the treatment of cutaneous melanoma
@en
Surgery and radiotherapy in the treatment of cutaneous melanoma.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Surgery and radiotherapy in the treatment of cutaneous melanoma
@en
P2093
A Hauschild
A M M Eggermont
P2860
P304
P356
10.1093/ANNONC/MDP257
P478
20 Suppl 6
P577
2009-08-01T00:00:00Z